It is rational to consider a hemodialysis strategy that is effective as renal support treatment while at the same time providing immunoprotection and immunomodulation through the removal of inflammatory mediators generated by immune cells involved in the advancement of the disease.
In a recent Spotlight article published in The Lancet Respiratory Medicine Claudio Ronco, Paolo Navalesi and Jean Louis Vincent discuss the possible role of extracorporeal organ support therapies in the intensive care unit during a viral outbreak, like the current COVID-19.
W have summarized the clinical experiences currently available in literature with the use of Polymyxin B hemoperfusion in patients with viral infection (H1N1-H5N1 influenza) who developed severe pneumonia or ARDS.
CORONAVIRUS DISEASE (COVID-19) OUTBREAK At the end of 2019, a novel coronavirus (initially named 2019-nCoV, now SARS-CoV-2) was found to be responsible for a cluster of atypical cases of pneumonia in Wuhan, China. Since then, the virus has spread both inside and outside China, and the WHO has declared this a public health emergency. Coronavirus is one […]
The Réanimation 2020 meeting organized by SRLF (Société de Réanimation de Langue Française) takes place from February 5-7, 2020, at Porte de Versailles in Paris, France.
We will be present with exposition area (booth #109) and on February 5th we will support the atelier: CHOC SEPTIQUE ET POLYMYXINE B EN HÉMOPERFUSION
Today, on October 11th 2019, we celebrate our company’s 20 years anniversary. On this occasion, we would like to thank our customers, partners, collaborators, and all those who believe in what we are working so hard to accomplish: EXCELLENCE IN HEALTHCARE. We appreciate your continued support and look forward to an exciting future! Read the message from our President: 20 years of challenges and new projects!
We support World Sepsis Day (September 13), aiming to raise awareness of sepsis, a clinical emergency correlated with high mortality and morbidity.
